Sunday, November 19, 2017
 
 
Company News: Page (1) of 1 - 09/06/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Actelion Receives FDA Approval Of TRACLEER® (bosentan) For Use In Pediatric Patients With Pulmonary Arterial Hypertension
--First PAH medication approved in the U.S. for pediatric patients aged three years and older--
(September 06, 2017)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:USA, Inc.,Medicine,Diet,Disease,Sexual,Pregnancy,Surgery,Medication,Pregnancy,Nurse,Science,Medical,Science,Adults,Other,Medical Professionals,Men,Women,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines